Literature DB >> 12577307

Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate.

Hana Dolezalova1, Geetha Shankar, Mei-Chuan Huang, Daniel D Bikle, Edward J Goetzl.   

Abstract

G protein-coupled receptors (GPCRs) for lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P) transduce signals to many functions of normal cells. Most human cancer cells upregulate S1P and LPA GPCRs, in patterns distinctive for each type of tumor. The findings that 1-alpha, 25-dihydroxy-vitamin D(3) (VD3) and all-trans retinoic acid (RA) differentially alter expression of the predominant S1P(3) (Edg-3) R and S1P(2) (Edg-5) R in human breast cancer cells (BCCs) permitted analyses of their individual activities, despite a lack of selective pharmacological probes. S1P-evoked increases in [Ca(2+)](i) in S1P(3) R-predominant BCCs were suppressed by concentrations of VD3 and RA which decreased expression of S1P(3) Rs, despite RA-induced increases in S1P(2) Rs. S1P-elicited chemokinetic migration of S1P(3) R-predominant BCCs across a type IV collagen-coated micropore filter also was inhibited by concentrations of VD3 and RA which decreased expression of S1P(3) Rs. The RA-induced increase in expression of S1P(2) Rs did not prevent suppression by RA of S1P-elicited chemokinesis, which appears to be mediated by S1P(3) Rs, but instead exposed S1P(2) R-mediated inhibition of epidermal growth factor-stimulated chemotaxis of BCCs. In contrast, expression of the predominant LPA(2) Rs, LPA-evoked increase in [Ca(2+)](i) and LPA-stimulated chemokinetic migration were suppressed concomitantly by RA but not VD3. Thus two structurally-homologous S1P Rs of BCCs differ in coupling to [Ca(2+)](i) signaling and have opposite effects on protein growth factor-stimulated chemotaxis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12577307     DOI: 10.1002/jcb.10394

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

1.  Falling from grace: HPRT is not suitable as an endogenous control for cancer-related studies.

Authors:  Michelle H Townsend; Abigail M Felsted; Zac E Ence; Stephen R Piccolo; Richard A Robison; Kim L O'Neill
Journal:  Mol Cell Oncol       Date:  2019-02-26

2.  Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells.

Authors:  Sonja Balthasar; Johanna Samulin; Hanna Ahlgren; Nina Bergelin; Mathias Lundqvist; Emil C Toescu; Margaret C Eggo; Kid Törnquist
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

Review 3.  Role of G12 proteins in oncogenesis and metastasis.

Authors:  Juhi Juneja; Patrick J Casey
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

4.  Expression of sphingosine-1-phosphate receptors and lysophosphatidic acid receptors on cultured and xenografted human colon, breast, melanoma, and lung tumor cells.

Authors:  Reinhard Müller; Christoph Berliner; Jessica Leptin; Daniel Pörtner; Wojciech Bialecki; Burkhard Kleuser; Udo Schumacher; Novica M Milićević
Journal:  Tumour Biol       Date:  2010-05-18

Review 5.  Targeting sphingosine-1-phosphate receptors in cancer.

Authors:  Rebecca J Watters; Hong-Gang Wang; Shen-Shu Sung; Thomas P Loughran; Xin Liu
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

6.  Sphingosine 1-phosphate analogue recognition and selectivity at S1P4 within the endothelial differentiation gene family of receptors.

Authors:  Yuichi Inagaki; Trucchi T Pham; Yuko Fujiwara; Takayuki Kohno; Daniel A Osborne; Yasuyuki Igarashi; Gabor Tigyi; Abby L Parrill
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

Review 7.  Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system.

Authors:  Mercedes Garcia-Gil; Federica Pierucci; Ambra Vestri; Elisabetta Meacci
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

8.  In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody.

Authors:  Greg L Harris; Michael B Creason; Greg B Brulte; Deron R Herr
Journal:  PLoS One       Date:  2012-04-05       Impact factor: 3.240

9.  A method for the prediction of GPCRs coupling specificity to G-proteins using refined profile Hidden Markov Models.

Authors:  Nikolaos G Sgourakis; Pantelis G Bagos; Panagiotis K Papasaikas; Stavros J Hamodrakas
Journal:  BMC Bioinformatics       Date:  2005-04-22       Impact factor: 3.169

Review 10.  Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment.

Authors:  Yamila I Rodriguez; Ludmila E Campos; Melina G Castro; Ahmed Aladhami; Carole A Oskeritzian; Sergio E Alvarez
Journal:  Front Oncol       Date:  2016-10-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.